Thermo Fisher Scientific Inc. ( NYSE:TMO ) shareholders might be concerned after seeing the share price drop 10% in ...
WALTHAM, Mass., November 15, 2024--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the ...
AZoM on MSN5d
How Clean-Burning Hydrogen Can Combat Climate ChangeThe United Nations (UN) has reiterated the need to expedite projected emissions reductions from the use of fossil fuels.
DelveInsight's D-Dimer Testing Market Insights report provides the current and forecast market analysis, individual leading D ...
The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise ...
The global gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2 ...
GlobalData on MSN1d
Adaptimmune nears second sarcoma approval as Phase II trial hits endpointsAdaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.
McDonald’s Corp. sold its first Swiss franc-denominated bond since 2016, with the deal coming in the wake of an E. coli ...
The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback